Search Within

Genitourinary Oncology Service

  1. "William Kelly"
Formats
  1. Journal Article (58)
  2. Meeting Abstract (20)
  3. Conference Paper (2)
  4. Book Section (1)
Groups
  1. Department of Medicine (81)
  2. Solid Tumor Oncology Division (81)
  3. Hematologic Malignancies, Division of (32)
  4. Nursing (29)
  5. GSK Faculty (23)
  6. Radiology, Department of (21)

More Groups

People
  1. William Kelly (81)
  2. Howard Scher (76)
  3. Susan Slovin (31)
  4. Michael Morris (24)
  5. Tracy Smart-Curley (22)
  6. Lawrence Schwartz (18)

More People

Years
  1. 2017 (1)
  2. 2016 (1)
  3. 2009 (2)
  4. 2007 (3)
  5. 2006 (1)
  6. 2005 (15)

More Years

Publications
  1. Journal of Clinical Oncology (28)
  2. Clinical Cancer Research (13)
  3. Urology (6)
  4. Cancer (5)
  5. Journal of Urology (5)
  6. Proceedings of the American Association for Cancer Research Annual Meeting (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (28)
  2. American Association for Cancer Research (16)
  3. Elsevier Science, Inc. (12)
  4. Elsevier Inc. (7)
  5. Wiley Blackwell (5)
  6. Lippincott Williams & Wilkins (3)

More Publishers

Results (81)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Circulating tumor cells (CTCs) N-terminal androgen receptor expression to identify patients (pts) with castrate resistant prostate cancer (CRPC) who are more sensitive to chemotherapy
    Meeting Abstract

    Slovin, S. F.; Knudsen, K. E.; Halabi, S.; Carbone, E.; Fernandez, C.; Chen, Y.; Autio, K. A.; Rathkopf, D. E.; Kampel, L.; Morris, M. J.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Exploring the role of RB and AR in a phase II randomized multicenter trial of abiraterone acetate with or without cabazitaxel in metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Slovin, S. F.; Knudsen, K. E.; Carbone, E.; Showunmi, A.; Hullings, M.; Morris, M. J.; Autio, K. A.; Kampel, L. J.; Molina, A. M.; Chen, Y.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Anti-epidermal growth factor receptor monoclonal antibody cetuximab plus doxorubicin in the treatment of metastatic castration-resistant prostate cancer
    Journal Article

    Slovin, S. F.; Kelly, W. K.; Wilton, A.; Kattan, M.; Myskowski, P.; Mendelsohn, J.; Scher, H. I.
    Clinical Genitourinary Cancer (2009)

    Fulltext@MSK | Save
  • Phase 1 Trial of High-Dose Exogenous Testosterone in Patients with Castration-Resistant Metastatic Prostate Cancer
    Journal Article

    Morris, M. J.; Huang, D.; Kelly, W. K.; Slovin, S. F.; Stephenson, R. D.; Eicher, C.; Delacruz, A.; Curley, T.; Schwartz, L. H.; Scher, H. I.
    European Urology (2009)

    Fulltext@MSK | Save
  • The Prostate Cancer Clinical Trials Working Group (PCCTWG) consensus criteria for phase II clinical trials for castration-resistant prostate cancer
    Meeting Abstract

    Scher, H. I.; Halabi, S.; Tannock, I.; Morris, M.; Higano, C.; Kelly, W.; Sternberg, C.; Eisenberger, M.; Martin, A.; Hussain, M.; more...
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer
    Journal Article

    Solit, D. B.; Ivy, S. P.; Kopil, C.; Sikorski, R.; Morris, M. J.; Slovin, S. F.; Kelly, W. K.; Delacruz, A.; Curley, T.; Heller, G.; more...
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • A phase II trial of bortezomib and prednisone for castration resistant metastatic prostate cancer
    Journal Article

    Morris, M. J.; Kelly, W. K.; Slovin, S.; Ryan, C.; Eicher, C.; Heller, G.; Scher, H. I.
    Journal of Urology (2007)

    Fulltext@MSK | Save
  • Pharmacokinetics and toxicity of weekly docetaxel in older patients
    Journal Article

    Hurria, A.; Fleming, M. T.; Baker, S. D.; Kelly, Wm K.; Cutchall, K.; Panageas, K.; Caravelli, J.; Yeung, H.; Kris, M. G.; Gomez, J.; more...
    Clinical Cancer Research (2006)

    Fulltext@MSK | Save
  • Phase 1 pharmacokinetic and pharmacodynamic trial of docetaxel and 17AAG (17-allylamino-17-demethoxygeldanamycin)
    Meeting Abstract

    Solit, D. B.; Egorin, M.; Kopil, C.; Delacruz, A.; Shaffer, D.; Slovin, S.; Morris, M.; Kelly, W. K.; Rosen, N.; Scher, H.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • The men's cycle plus docetaxel (Doc) in prostate cancer patients with rising PSAs in the non-castrate state
    Meeting Abstract

    Slovin, S. F.; Carducci, M. A.; Beekman, K. W.; Pili, R.; Eicher, C.; Kelly, W. K.; Morris, M. J.; Shaffer, D.; Eisenberger, M.; Scher, H. I.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save